GO:0090230 | regulation of centromere complex assembly | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0031134 | sister chromatid biorientation | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0051683 | establishment of Golgi localization | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0072384 | organelle transport along microtubule | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 2 |
GO:0005968 | Rab-protein geranylgeranyltransferase complex | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0030157 | pancreatic juice secretion | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 2 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0090136 | epithelial cell-cell adhesion | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 2 | 4 |
GO:0036336 | dendritic cell migration | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0031256 | leading edge membrane | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0004663 | Rab geranylgeranyltransferase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0018344 | protein geranylgeranylation | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0007097 | nuclear migration | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 2 | 5 |
GO:0031274 | positive regulation of pseudopodium assembly | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0003334 | keratinocyte development | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0060789 | hair follicle placode formation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0043353 | enucleate erythrocyte differentiation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0000075 | cell cycle checkpoint | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0051489 | regulation of filopodium assembly | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0060047 | heart contraction | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0030126 | COPI vesicle coat | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0051233 | spindle midzone | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 8 |
GO:0097284 | hepatocyte apoptotic process | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 9 |
GO:0031996 | thioesterase binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 9 |
GO:0042551 | neuron maturation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 10 |
GO:0045651 | positive regulation of macrophage differentiation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 10 |
GO:0043488 | regulation of mRNA stability | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 10 |
GO:0031333 | negative regulation of protein complex assembly | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0030742 | GTP-dependent protein binding | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0006612 | protein targeting to membrane | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0090316 | positive regulation of intracellular protein transport | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0030225 | macrophage differentiation | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0007088 | regulation of mitosis | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 12 |
GO:0045445 | myoblast differentiation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 13 |
GO:0016514 | SWI/SNF complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 13 |
GO:0046847 | filopodium assembly | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 14 |
GO:0042176 | regulation of protein catabolic process | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 3 | 14 |
GO:0045859 | regulation of protein kinase activity | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 14 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 15 |
GO:0045879 | negative regulation of smoothened signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 15 |
GO:0051017 | actin filament bundle assembly | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 15 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 16 |
GO:0032467 | positive regulation of cytokinesis | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 16 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 17 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0031069 | hair follicle morphogenesis | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0048565 | digestive tract development | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 4 | 19 |
GO:0007163 | establishment or maintenance of cell polarity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 20 |
GO:0072686 | mitotic spindle | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 20 |
GO:0007346 | regulation of mitotic cell cycle | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0031647 | regulation of protein stability | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 2 | 22 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 1 | 22 |
GO:0002040 | sprouting angiogenesis | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 1 | 22 |
GO:0031424 | keratinization | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 1 | 23 |
GO:0042802 | identical protein binding | 1.22e-02 | 1.00e+00 | 3.464 | 2 | 2 | 354 |
GO:0007030 | Golgi organization | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0007093 | mitotic cell cycle checkpoint | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 25 |
GO:0051219 | phosphoprotein binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 3 | 25 |
GO:0034613 | cellular protein localization | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 26 |
GO:0050896 | response to stimulus | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 27 |
GO:0034332 | adherens junction organization | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 28 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 28 |
GO:0042692 | muscle cell differentiation | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 28 |
GO:0051402 | neuron apoptotic process | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 30 |
GO:0050681 | androgen receptor binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 30 |
GO:0016020 | membrane | 1.55e-02 | 1.00e+00 | 2.279 | 3 | 25 | 1207 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.58e-02 | 1.00e+00 | 5.977 | 1 | 1 | 31 |
GO:0001568 | blood vessel development | 1.58e-02 | 1.00e+00 | 5.977 | 1 | 1 | 31 |
GO:0045740 | positive regulation of DNA replication | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 32 |
GO:0019900 | kinase binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 32 |
GO:0035914 | skeletal muscle cell differentiation | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 33 |
GO:0021762 | substantia nigra development | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 2 | 34 |
GO:0046330 | positive regulation of JNK cascade | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 3 | 35 |
GO:0030175 | filopodium | 1.88e-02 | 1.00e+00 | 5.722 | 1 | 2 | 37 |
GO:0050680 | negative regulation of epithelial cell proliferation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 39 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.08e-02 | 1.00e+00 | 5.574 | 1 | 2 | 41 |
GO:0001047 | core promoter binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 42 |
GO:0017137 | Rab GTPase binding | 2.18e-02 | 1.00e+00 | 5.505 | 1 | 1 | 43 |
GO:0030141 | secretory granule | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 44 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 45 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 48 |
GO:0006469 | negative regulation of protein kinase activity | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 1 | 50 |
GO:0060070 | canonical Wnt signaling pathway | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 51 |
GO:0031295 | T cell costimulation | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 51 |
GO:0045177 | apical part of cell | 2.74e-02 | 1.00e+00 | 5.177 | 1 | 1 | 54 |
GO:0035264 | multicellular organism growth | 2.74e-02 | 1.00e+00 | 5.177 | 1 | 1 | 54 |
GO:0006338 | chromatin remodeling | 2.79e-02 | 1.00e+00 | 5.150 | 1 | 2 | 55 |
GO:0031175 | neuron projection development | 2.79e-02 | 1.00e+00 | 5.150 | 1 | 2 | 55 |
GO:0000785 | chromatin | 2.99e-02 | 1.00e+00 | 5.049 | 1 | 2 | 59 |
GO:0007265 | Ras protein signal transduction | 2.99e-02 | 1.00e+00 | 5.049 | 1 | 2 | 59 |
GO:0005179 | hormone activity | 3.04e-02 | 1.00e+00 | 5.025 | 1 | 1 | 60 |
GO:0010629 | negative regulation of gene expression | 3.14e-02 | 1.00e+00 | 4.977 | 1 | 2 | 62 |
GO:0005096 | GTPase activator activity | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 3 | 68 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 3 | 70 |
GO:0070062 | extracellular vesicular exosome | 3.63e-02 | 1.00e+00 | 1.836 | 3 | 28 | 1641 |
GO:0030496 | midbody | 3.68e-02 | 1.00e+00 | 4.742 | 1 | 3 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 3.83e-02 | 1.00e+00 | 4.684 | 1 | 1 | 76 |
GO:0005815 | microtubule organizing center | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 77 |
GO:0016605 | PML body | 3.98e-02 | 1.00e+00 | 4.628 | 1 | 1 | 79 |
GO:0005819 | spindle | 4.03e-02 | 1.00e+00 | 4.610 | 1 | 2 | 80 |
GO:0061024 | membrane organization | 4.48e-02 | 1.00e+00 | 4.456 | 1 | 3 | 89 |
GO:0006886 | intracellular protein transport | 4.48e-02 | 1.00e+00 | 4.456 | 1 | 1 | 89 |
GO:0030036 | actin cytoskeleton organization | 4.53e-02 | 1.00e+00 | 4.440 | 1 | 2 | 90 |
GO:0005829 | cytosol | 4.57e-02 | 1.00e+00 | 1.713 | 3 | 33 | 1787 |
GO:0007050 | cell cycle arrest | 4.62e-02 | 1.00e+00 | 4.408 | 1 | 2 | 92 |
GO:0007601 | visual perception | 4.87e-02 | 1.00e+00 | 4.332 | 1 | 1 | 97 |
GO:0005198 | structural molecule activity | 5.07e-02 | 1.00e+00 | 4.273 | 1 | 1 | 101 |
GO:0005911 | cell-cell junction | 5.21e-02 | 1.00e+00 | 4.231 | 1 | 2 | 104 |
GO:0010628 | positive regulation of gene expression | 5.31e-02 | 1.00e+00 | 4.204 | 1 | 2 | 106 |
GO:0043547 | positive regulation of GTPase activity | 5.61e-02 | 1.00e+00 | 4.124 | 1 | 4 | 112 |
GO:0042981 | regulation of apoptotic process | 5.61e-02 | 1.00e+00 | 4.124 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 5.65e-02 | 1.00e+00 | 4.111 | 1 | 2 | 113 |
GO:0003924 | GTPase activity | 5.95e-02 | 1.00e+00 | 4.037 | 1 | 3 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6.24e-02 | 1.00e+00 | 3.966 | 1 | 6 | 125 |
GO:0006184 | GTP catabolic process | 6.48e-02 | 1.00e+00 | 3.909 | 1 | 3 | 130 |
GO:0031625 | ubiquitin protein ligase binding | 6.87e-02 | 1.00e+00 | 3.823 | 1 | 2 | 138 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 7.06e-02 | 1.00e+00 | 3.782 | 1 | 3 | 142 |
GO:0043025 | neuronal cell body | 8.46e-02 | 1.00e+00 | 3.514 | 1 | 3 | 171 |
GO:0007264 | small GTPase mediated signal transduction | 8.60e-02 | 1.00e+00 | 3.489 | 1 | 4 | 174 |
GO:0003713 | transcription coactivator activity | 9.07e-02 | 1.00e+00 | 3.408 | 1 | 3 | 184 |
GO:0005525 | GTP binding | 9.69e-02 | 1.00e+00 | 3.309 | 1 | 3 | 197 |
GO:0008134 | transcription factor binding | 1.03e-01 | 1.00e+00 | 3.224 | 1 | 5 | 209 |
GO:0019901 | protein kinase binding | 1.13e-01 | 1.00e+00 | 3.073 | 1 | 8 | 232 |
GO:0007411 | axon guidance | 1.16e-01 | 1.00e+00 | 3.043 | 1 | 2 | 237 |
GO:0005737 | cytoplasm | 1.25e-01 | 1.00e+00 | 1.154 | 3 | 39 | 2633 |
GO:0000139 | Golgi membrane | 1.29e-01 | 1.00e+00 | 2.871 | 1 | 4 | 267 |
GO:0005925 | focal adhesion | 1.36e-01 | 1.00e+00 | 2.792 | 1 | 12 | 282 |
GO:0000278 | mitotic cell cycle | 1.51e-01 | 1.00e+00 | 2.637 | 1 | 9 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.52e-01 | 1.00e+00 | 2.623 | 1 | 1 | 317 |
GO:0007596 | blood coagulation | 1.62e-01 | 1.00e+00 | 2.526 | 1 | 4 | 339 |
GO:0048471 | perinuclear region of cytoplasm | 1.64e-01 | 1.00e+00 | 2.505 | 1 | 7 | 344 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.79e-01 | 1.00e+00 | 2.373 | 1 | 6 | 377 |
GO:0016032 | viral process | 2.01e-01 | 1.00e+00 | 2.190 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 2.11e-01 | 1.00e+00 | 2.111 | 1 | 6 | 452 |
GO:0005886 | plasma membrane | 2.28e-01 | 1.00e+00 | 1.131 | 2 | 13 | 1784 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.65e-01 | 1.00e+00 | 1.747 | 1 | 9 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.89e-01 | 1.00e+00 | 1.601 | 1 | 8 | 644 |
GO:0005615 | extracellular space | 2.92e-01 | 1.00e+00 | 1.585 | 1 | 2 | 651 |
GO:0044822 | poly(A) RNA binding | 3.47e-01 | 1.00e+00 | 1.289 | 1 | 25 | 799 |
GO:0005515 | protein binding | 3.57e-01 | 1.00e+00 | 0.507 | 3 | 50 | 4124 |
GO:0005654 | nucleoplasm | 3.75e-01 | 1.00e+00 | 1.157 | 1 | 16 | 876 |
GO:0003677 | DNA binding | 4.00e-01 | 1.00e+00 | 1.044 | 1 | 12 | 947 |
GO:0006351 | transcription, DNA-templated | 4.42e-01 | 1.00e+00 | 0.860 | 1 | 15 | 1076 |
GO:0005634 | nucleus | 5.37e-01 | 1.00e+00 | 0.267 | 2 | 40 | 3246 |